Close Menu
Chicago News Journal
    Facebook X (Twitter) Instagram
    • Contact us
    • About us
    • Amazon Disclaimer
    • DMCA / Copyrights Disclaimer
    • Privacy Policy
    • Terms and Conditions
    Facebook X (Twitter) Instagram YouTube TikTok
    Chicago News JournalChicago News Journal
    • Home
    • US News
    • Politics
    • Business
    • Science
    • Technology
    • LifeStyle
    • Music
    • Television
    • Film
    • Books
    • Contact
      • About us
      • Amazon Disclaimer
      • DMCA / Copyrights Disclaimer
      • Privacy Policy
      • Terms and Conditions
    Chicago News Journal
    Home»Business

    Eli Lilly to build $6 billion Alabama manufacturing plant

    AdminBy AdminDecember 10, 2025 Business
    Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram
    Eli Lilly to build $6 billion Alabama manufacturing plant

    Eli Lilly CEO David A. Ricks speaks at a press conference at Generation Park in Houston, Monday, Sept. 23, 2025. The company announced plans for a $6.5 billion biomanufacturing plant in north Houston. (Raquel Natalicchio/Houston Chronicle via Getty Images)

    Raquel Natalicchio | Houston Chronicle | Getty Images

    Eli Lilly on Tuesday said it will spend $6 billion to build a manufacturing plant in Huntsville, Alabama, to help boost production of its closely watched experimental obesity pill and other drugs. 

    It is the third facility in a string of new planned U.S. investments by the drugmaker. Eli Lilly announced in February that it would spend at least $27 billion to build four new domestic manufacturing plants, adding to $23 billion in previous investments since 2020.

    The company said it expects construction of the Alabama plant to start in 2026 and for it to be completed in 2032. 

    “Today’s investment continues the onshoring of active pharmaceutical ingredient (API) production, strengthening supply chain resilience and reliable access to medicines for patients in the U.S.,” said Eli Lilly CEO David Ricks in a release. 

    That added production capacity for Eli Lilly’s obesity pill, orforglipron, is crucial as the company races to file for its approval and tries to maintain its dominance in the booming market for GLP-1s. The company and its chief rival, Novo Nordisk, faced supply shortages for their existing weekly injections after demand skyrocketed in the U.S. in recent years, though they have managed to alleviate those issues.

    Eli Lily’s pill in November won a priority review voucher from the Food and Drug Administration, which will significantly speed up the regulator’s assessment of the drug to potentially a few months. 

    Drugmakers have been scrambling to boost their production in the U.S. after threats by President Donald Trump to impose tariffs on pharmaceuticals imported into the U.S. But concerns about those potential tariffs have eased following recent drug pricing deals with Trump that exempt companies from the levies.

    Eli Lilly said the Alabama site will bring 450 jobs to the area, including engineers, scientists, operations personnel and lab technicians, as well as 3,000 construction jobs. 

    Read the original article here

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram

    You might also be interested in...

    Over 314,000 older Toyota and Lexus vehicles recalled for potentially dangerous airbag issue

    November 20, 2026

    Anthropic prices IPO at $83 a share, blowing past target range: report

    November 19, 2026

    California DMV boots Waymo robotaxis off state freeways after string of incidents

    November 18, 2026

    Chipotle launches Sneak It In hoodies with hidden pouch to keep your burrito warm

    November 17, 2026

    Big-ticket holiday items may be harder to find as shipping costs rise

    November 16, 2026

    Jensen Huang weighs Nvidia CEO comeback as ally plans war room: report

    November 16, 2026
    Popular Posts

    Bruno Mars Mourns His Fathers Death: The Man That Taught Me Everything I Know

    RHONJ Fans Less Than Impressed With Season 15 Sneak Peek

    Director Steve Miner Has Shot New Friday the 13th Movie

    JPMorganChase reports cyberattack on third-party service providers

    Fantasy and Science Fiction Books Where the Rules Dont Apply – NewInBooks

    Book Riots Deals of the Day for November 19, 2026

    Categories
    • Books (2,459)
    • Business (3,450)
    • Events (34)
    • Film (1,064)
    • LifeStyle (2,924)
    • Music (2,798)
    • Politics (2,356)
    • Science (1,954)
    • Technology (1,819)
    • Television (3,630)
    • US News (3,295)
    Archives
    Useful Links
    • Contact us
    • About us
    • Amazon Disclaimer
    • DMCA / Copyrights Disclaimer
    • Privacy Policy
    • Terms and Conditions
    Popular Posts
    • Car purchases rise, consumer spending slowsCar purchases rise, consumer spending slows
    • Best Football Movies | MoviefoneBest Football Movies | Moviefone
    • ‘Mother of the Bride’ Trailer Stars Brooke Shields, Miranda Cosgrove‘Mother of the Bride’ Trailer Stars Brooke Shields, Miranda Cosgrove
    • Jamie Dimon calls U.S. government ‘inefficient,’ touts Elon Musk’s DOGE effortJamie Dimon calls U.S. government ‘inefficient,’ touts Elon Musk’s DOGE effort
    • XEC: What we know about the new covid-19 variant and its symptomsXEC: What we know about the new covid-19 variant and its symptoms
    Archives
    Categories
    • Books
    • Business
    • Events
    • Film
    • LifeStyle
    • Music
    • Politics
    • Science
    • Technology
    • Television
    • US News
    Facebook X (Twitter) Instagram YouTube TikTok
    © 2026 Chicago News Journal. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Terms of Use and Privacy Policy.

    Type above and press Enter to search. Press Esc to cancel.